HeartBeam wins FDA breakthrough tag for at-home heart attack tool
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
October 5, 2026 8:31 AM EDTDesignation recognizes the potential of HeartBeams 3D ECG technology to help physicians assess suspected heart attacks outside the hospitalBreakthrough status provides prioritized FDA interaction as HeartBeam advances toward a pivotal studyDesignation positions HeartBeam to pursue an expedited Medicare coverage pathwayUpdates on ALIGN-ACS data at TCT and the HEADSTART-ACS study expected in coming weeks
SANTA CLARA, Calif.--(BUSINESS WIRE)--
... More


